Monthly Update1 April 2026 at 10:59 am
Genomic Valley Biotech Promoters Declare No Encumbrances for FY 2025-2026
AI Summary
Genomic Valley Biotech Ltd. announces that its promoters, including Yogesh Agrawal, Parul Agrawal, and Ojaswini Avantika, have not made any encumbrances directly or indirectly during the financial year ended 31st March 2026. This disclosure was made under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Highlights
- Genomic Valley Biotech promoters declare no encumbrances for FY 2025-2026
- Yogesh Agrawal, Parul Agrawal, and Ojaswini Avantika are included in the promoter group
- Disclosure made under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
- No indirect or direct encumbrances made during the financial year
GVBLBiotechnology
Genomic Valley Biotech LtdPrice Impact